BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17724373)

  • 21. Peroxisome proliferator-activated receptor gamma-dependent activity of indole ring-substituted 1,1-bis(3'-indolyl)-1-(p-biphenyl)methanes in cancer cells.
    Guo J; Chintharlapalli S; Lee SO; Cho SD; Lei P; Papineni S; Safe S
    Cancer Chemother Pharmacol; 2010 May; 66(1):141-50. PubMed ID: 19823826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time-dependent vascular actions of cannabidiol in the rat aorta.
    O'Sullivan SE; Sun Y; Bennett AJ; Randall MD; Kendall DA
    Eur J Pharmacol; 2009 Jun; 612(1-3):61-8. PubMed ID: 19285060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disruption of ERalpha signalling pathway by PPARgamma agonists: evidences of PPARgamma-independent events in two hormone-dependent breast cancer cell lines.
    Lecomte J; Flament S; Salamone S; Boisbrun M; Mazerbourg S; Chapleur Y; Grillier-Vuissoz I
    Breast Cancer Res Treat; 2008 Dec; 112(3):437-51. PubMed ID: 18204896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce apoptosis and inhibit renal cell carcinoma growth.
    York M; Abdelrahim M; Chintharlapalli S; Lucero SD; Safe S
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6743-52. PubMed ID: 18006776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of bioactive compounds from flowers of black elder (Sambucus nigra L.) that activate the human peroxisome proliferator-activated receptor (PPAR) gamma.
    Christensen KB; Petersen RK; Kristiansen K; Christensen LP
    Phytother Res; 2010 Jun; 24 Suppl 2():S129-32. PubMed ID: 20222152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisome proliferator-activated receptor gamma is highly expressed in pancreatic cancer and is associated with shorter overall survival times.
    Kristiansen G; Jacob J; Buckendahl AC; Grützmann R; Alldinger I; Sipos B; Klöppel G; Bahra M; Langrehr JM; Neuhaus P; Dietel M; Pilarsky C
    Clin Cancer Res; 2006 Nov; 12(21):6444-51. PubMed ID: 17085658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells.
    Choi SS; Cha BY; Lee YS; Yonezawa T; Teruya T; Nagai K; Woo JT
    Life Sci; 2009 Jun; 84(25-26):908-14. PubMed ID: 19376135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity.
    Fang XK; Gao J; Zhu DN
    Life Sci; 2008 Mar; 82(11-12):615-22. PubMed ID: 18262572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
    Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
    Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Curcumin exerts antidifferentiation effect through AMPKalpha-PPAR-gamma in 3T3-L1 adipocytes and antiproliferatory effect through AMPKalpha-COX-2 in cancer cells.
    Lee YK; Lee WS; Hwang JT; Kwon DY; Surh YJ; Park OJ
    J Agric Food Chem; 2009 Jan; 57(1):305-10. PubMed ID: 19093868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation and growth inhibition mediated via the RXR:PPARgamma heterodimer in colon cancer.
    Cesario RM; Stone J; Yen WC; Bissonnette RP; Lamph WW
    Cancer Lett; 2006 Aug; 240(2):225-33. PubMed ID: 16271436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-dependent activation of peroxisome proliferator-activated receptor (PPAR) gamma by organotin compounds.
    Hiromori Y; Nishikawa J; Yoshida I; Nagase H; Nakanishi T
    Chem Biol Interact; 2009 Jul; 180(2):238-44. PubMed ID: 19497422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rosiglitazone induces caveolin-1 by PPARgamma-dependent and PPRE-independent mechanisms: the role of EGF receptor signaling and its effect on cancer cell drug resistance.
    Tencer L; Burgermeister E; Ebert MP; Liscovitch M
    Anticancer Res; 2008; 28(2A):895-906. PubMed ID: 18507034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Berberine increases expression of GATA-2 and GATA-3 during inhibition of adipocyte differentiation.
    Hu Y; Davies GE
    Phytomedicine; 2009 Sep; 16(9):864-73. PubMed ID: 19403287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [PPARgamma and cancer].
    Nakagama H
    Nihon Rinsho; 2010 Feb; 68(2):323-9. PubMed ID: 20158104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Luteolin inhibits adipogenic differentiation by regulating PPARgamma activation.
    Park HS; Kim SH; Kim YS; Ryu SY; Hwang JT; Yang HJ; Kim GH; Kwon DY; Kim MS
    Biofactors; 2009; 35(4):373-9. PubMed ID: 19353690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptor gamma-independent effects of thiazolidinediones on human cardiac myofibroblast function.
    Mughal RS; Warburton P; O'Regan DJ; Ball SG; Turner NA; Porter KE
    Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):478-86. PubMed ID: 19673929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states.
    Muise ES; Azzolina B; Kuo DW; El-Sherbeini M; Tan Y; Yuan X; Mu J; Thompson JR; Berger JP; Wong KK
    Mol Pharmacol; 2008 Aug; 74(2):403-12. PubMed ID: 18467542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 13-Oxo-ODE is an endogenous ligand for PPARgamma in human colonic epithelial cells.
    Altmann R; Hausmann M; Spöttl T; Gruber M; Bull AW; Menzel K; Vogl D; Herfarth H; Schölmerich J; Falk W; Rogler G
    Biochem Pharmacol; 2007 Aug; 74(4):612-22. PubMed ID: 17604003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of peroxisome proliferator-activated receptor-gamma (PPARgamma) during liver regeneration in rats.
    Yamamoto Y; Ono T; Dhar DK; Yamanoi A; Tachibana M; Tanaka T; Nagasue N
    J Gastroenterol Hepatol; 2008 Jun; 23(6):930-7. PubMed ID: 18565023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.